Perspective Therapeutics, Inc.

CATX · Healthcare · Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (…

Perspective Therapeutics, Inc. (CATX), in the Healthcare sector, has 4 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 0 purchases and 4 sales, 1 filed past the deadline. Filers took a median of 3 days from execution to disclosure, and the most recent trade was executed Sep 4 and filed Sep 8. The most active filer was Lantheus Alpha Therapy, LLC with 3 filings.

Add to watchlist

Filings, ttm

0 buys · 4 sells · 1 late

Traders, ttm

2 insiders

Volume, ttmiDollar value disclosed in the window

$1.5M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 4

Filed Sep 8

ADViAverage daily dollar volume

$5.1M

market data

Share price · 12M

$3.13 (-5.2%)

Adjusted for splits and dividends.

Volume by month

Buys $100K Sells $1.5M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

LL Lantheus Alpha Therapy, LLC 10% owner 3 filings HH

Heidi Henson Director 1 filing LI Lantheus Holdings, Inc. 10% owner 1 filing

Recent filings

Lantheus Alpha Therapy, LLCSALE 10% owner $777K
247,932 sh across 2 lots
Exec Sep 3
Filed Sep 8 · 4:51 PM ET Lantheus Alpha Therapy, LLCSALE 10% owner $131K
42,129 sh × $3.11
Exec Sep 2
Filed Sep 4 · 5:00 PM ET Lantheus Alpha Therapy, LLCSALE 10% owner $357K
113,914 sh across 2 lots
Exec Aug 31
Filed Sep 4 · 4:58 PM ET † Lantheus Holdings, Inc.SALE 10% owner $246K
78,145 sh × $3.14
Exec Aug 31
Filed Sep 2 · 4:36 PM ET Heidi HensonPURCHASE Director $100K
25,975 sh × $3.85
Exec Dec 4 2024
Filed Dec 6 2024 · 5:30 PM ET